2-[2-Substituted-3-(3,4-dichlorobenzylamino)propylamino]-1H-quinolin-4-ones as Staphylococcus aureus methionyl-tRNA synthetase inhibitors

European Journal of Medicinal Chemistry

Volumn 44, Issue 1, 2009, Pages 239-250

  Farhanullah, ^a   Kang, Taehee ^b   Yoon, Eun Jung ^b   Choi, Eun Chil ^b   Kim, Sunghoon ^b   Lee, Jeewoo ^a  

^a Tumor Microenvironment Global Core Research Center   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Aminoacyl tRNA synthetase; Antibiotic; Methionyl tRNA synthetase inhibitors

Indexed keywords

2 QUINOLIN 4 ONE DERIVATIVE; AMOXICILLIN; LIGASE INHIBITOR; METHIONINE TRANSFER RNA LIGASE; METHIONINE TRANSFER RNA LIGASE INHIBITOR; PSEUDOMONIC ACID; QUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; DRUG SYNTHESIS; ENTEROCOCCUS; IC 50; NONHUMAN; REACTION ANALYSIS; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION;

ANTI-BACTERIAL AGENTS; ENTEROCOCCUS; METHIONINE-TRNA LIGASE; MICROBIAL SENSITIVITY TESTS; QUINOLONES; STAPHYLOCOCCUS AUREUS;

EID: 57949085824     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2008.02.021     Document Type: Article

References (18)

1. Ibba M., and Söll D. Annu. Rev. Biochem. 69 (2000) 617-650
2. Schimmel P., and Schmidt E. Trends Biochem. Sci. 20 (1995) 1-2
3. Ochsner U.A., Sun X., Jarvis T., Critchley I., and Janjic N. Expert Opin. Investig. Drugs 16 (2007) 573-593
4. Ataide S.F., and Ibba M. ACS Chem. Biol. 1 (2006) 285-297
5. Hurdle J.G., O′Neill A.J., and Chopra I. Antimicrob. Agents Chemother. 49 (2005) 4821-4833
6. Lee J., Kim S.E., Lee J.Y., Kim S.Y., Kang S.U., Seo S.H., Chun M.W., Kang T., Choi S.Y., and Kim H.O. Bioorg. Med. Chem. Lett. 13 (2003) 1087-1092
7. Kim S.E., Kim S.Y., Kim S., Kang T., and Lee J. Bioorg. Med. Chem. Lett. 15 (2005) 3389-3393
8. Jarvest R.L., Berge J.M., Berry V., Boyd H.F., Brown M.J., Elder J.S., Forrest A.K., Fosberry A.P., Gentry D.R., Hibbs M.J., Jaworski D.D., O′ Hanlon P.J., Pope A.J., Rittenhouse S., Sheppard R.J., Slater-Radosti C., and Worby A. J. Med. Chem. 45 (2002) 1959-1962
9. Jarvest R.L., Armstrong S.A., Berge J.M., Brown P., Elder J.S., Brown M.J., Copley R.C.B., Forrest A.K., Hamprecht D.W., O′ Hanlon P.J., Mitchell D.J., Rittenhouse S., and Witty D.R. Bioorg. Med. Chem. Lett. 14 (2004) 3937-3941
10. Jarvest R.L., Berge J.M., Brown P., Houge- Frydrych C.S.V., O′ Hanlon P.J., McNair D.J., Pope A.J., and Rittenhouse S. Bioorg. Med. Chem. Lett. 13 (2003) 1265-1268
11. Jarvest R.L., Berge J.M., Brown J.M., Brown P., Elder J.S., Forest A.K., Houge-Frydrych C.S.V., O′ Hanlon P.J., McNair D.J., Rittenhouse S., and Sheppard R.J. Bioorg. Med. Chem. Lett. 13 (2003) 665-668
12. Critchley I.A., Young C.L., Stone K.C., Ochsner U.A., Guiles J., Tarasow T., and Janjic N. Antimicrob. Agents Chemother. 49 (2005) 4247-4252
13. Ochsner U.A., Young C.L., Stone K.C., and Dean F.B. Antimicrob. Agents Chemother. 49 (2005) 4253-4262
14. Li T., Froeyen M., and Herdewijn P. J. Mol. Graph. Model. 26 (2008) 813-823
15. Jarvest R.L., Erskine S.G., Forest A.K., Fosberry A.P., Hibbs M.J., Jonnes J.J., O′ Hanlon P.J., Sheppard R.J., and Worby A. Bioorg. Med. Chem. Lett. 15 (2005) 2305-2309
16. Farhanullah S.Y., Kim E.-J., Yoon E.-C., Choi S., Kim T., Kang F., Samrin S., and PuriLee J. Bioorg. Med. Chem. 14 (2006) 7154-7159
17. Osborne G., Buley J.M., Clarke H., Dakin R.C.H., and Price C.I. J. Chem. Soc., Perkin Trans. 1 (1993) 2747-2755
18. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing; 15th Informational Supplement. Document M100-S15 (2005), CLSI, Wayne, PA